Srijana Pokhrel and Jasmine Tuazon named as OSU IDI NIH T32 Fellows

   

Postdoc Srijana Pokhrel and graduate student Jasmine Tuazon were selected as 2022-2023 fellows for the OSU Infectious Disease Institute’s NIH T32 entitled, “Interdisciplinary Program in Microbe-Host Biology”. They will be part of a cohort of 7 trainees (4 pre-doc, 3 post-doc) pursuing novel infectious disease immunology research and engaging in weekly host-pathogen forums over the year. Congratulations, Srijana and Jasmine!

Drs. Oestreich and Vaughn fundraise and ride for Pelotonia

As part of Pelotonia, a community cycling fundraiser to support cancer research at the OSU Comprehensive Cancer Center, Dr. Oestreich and Dr. Jennifer Vaughn completed a 38-mile ride. Drs. Oestreich and Vaughn participated as team members for the MII-ghty Bucks peloton, which raised over $14,000 dollars for cancer research! For more information on how you can help bring an end to cancer, please go to www.pelotonia.org.

Kaitlin Read invited for a podium talk at the 2022 FASEB Research Conference

Kaitlin Read, pictured here with MI&I Department Chair Eugene Oltz and MI&I Assistant Professor Jerry Lio, was selected to give a talk at the Federation of American Societies for Experimental Biology (FASEB) Research Conference in Nova Scotia, Canada. This conference, focused on “The Molecular Mechanisms of Immune Cell Development and Function,” was a prime place for Kaitlin to showcase the latter part of her dissertation work as she prepares for her next big step in her career. We are proud of you!

Dr. Oestreich becomes director of the Immunology and Immunotherapeutics Graduate Program (I2GP)

Oestreich-Ken

Dr. Oestreich is officially named director of the new Immunology and Immunotherapeutics Graduate Program (I2GP). This program enables students to concentrate in immunological areas including, but not limited to, cellular and molecular immunology, immunology of infectious diseases (host-pathogen interactions), translational immunology (immunotherapeutic and immuno-oncology, vaccine development) and systems immunology. Congrats, Dr. Oestreich!

Visit the I2GP website here.